932042-85-8
                            中文名称
                            紫杉醇EP杂质M
                            
                        
                        
                        
                            英文名称
                            β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8-yl Ester
                            
                        
                        
                        
                            CAS
                            
                            932042-85-8
                            
                        
                        
                        
                            分子式
                            C47H53NO15
                            
                        
                        
                        
                            分子量
                            871.92
                            
                        
                        
                        
                            MOL 文件
                            932042-85-8.mol
                            
                        
                        
                        
                            更新日期
                            
                            2024/08/23 09:06:33
                            
                        
                        
                    
                        932042-85-8 结构式
                    基本信息
中文别名
紫杉醇杂质27紫杉醇杂质41
紫杉醇杂质M (EP)
紫杉醇氧杂环丁烷开环3-乙酰基-4-苯甲酰杂质
紫杉醇氧杂环丁烷开环3-乙酰基4-苯甲酰基杂质
英文别名
Paclitaxel Impurity 41Paclitaxel Impurity 13(Paclitaxel EP Impurity M)
Paclitaxel Oxetane Ring-Opened 3-Acetyl 4-Benzoyl IMpurity
1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20-tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoate],
1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20- tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3- (benzoylamino)-2-hydroxy-3-phenylpropanoate
Paclitaxel EP Impurity M 1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20- tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3- (benzoylamino)-2-hydroxy-3-phenylpropanoate
Paclitaxel EP Impurity M 1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20- tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3- (benzoylamino)-2-hydroxy-3-phenylpropanoate]
(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-6,10-methanobenzocyclodecen-8-yl(αR,βS)-β-(benzoylamino)-α-hydroxybenzenepropanoate
β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8-yl Ester
Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-bis(acetyloxy)-4-[(benzoyloxy)methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-6,10-methanobenzocyclodecen-8-yl ester, (αR,βS)-